ZA927432B - Chemical compounds. - Google Patents

Chemical compounds.

Info

Publication number
ZA927432B
ZA927432B ZA927432A ZA927432A ZA927432B ZA 927432 B ZA927432 B ZA 927432B ZA 927432 A ZA927432 A ZA 927432A ZA 927432 A ZA927432 A ZA 927432A ZA 927432 B ZA927432 B ZA 927432B
Authority
ZA
South Africa
Prior art keywords
acid
nucleosides
fatty acid
ara
esters
Prior art date
Application number
ZA927432A
Other languages
English (en)
Inventor
Are Dalen
Finn Myhren
Bernt Borretzen
Kjell Torgeir Stokke
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Publication of ZA927432B publication Critical patent/ZA927432B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • External Artificial Organs (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA927432A 1991-10-07 1992-09-28 Chemical compounds. ZA927432B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9121257A GB2260319B (en) 1991-10-07 1991-10-07 Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity

Publications (1)

Publication Number Publication Date
ZA927432B true ZA927432B (en) 1993-06-09

Family

ID=10702531

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA927432A ZA927432B (en) 1991-10-07 1992-09-28 Chemical compounds.

Country Status (26)

Country Link
US (1) US6548486B1 (fr)
EP (1) EP0642525B1 (fr)
JP (1) JP2873313B2 (fr)
KR (1) KR100272732B1 (fr)
AT (1) ATE152454T1 (fr)
CA (1) CA2120725C (fr)
CH (1) CH0642525H1 (fr)
CZ (1) CZ288153B6 (fr)
DE (1) DE69219482T2 (fr)
DK (1) DK0642525T3 (fr)
FI (2) FI990270A0 (fr)
GB (1) GB2260319B (fr)
GR (1) GR3024149T3 (fr)
HU (1) HU219400B (fr)
IL (1) IL103351A (fr)
MX (1) MX9205715A (fr)
NO (1) NO300014B1 (fr)
NZ (1) NZ244535A (fr)
PL (1) PL170846B1 (fr)
RU (1) RU2126417C1 (fr)
SG (1) SG47759A1 (fr)
SK (1) SK281903B6 (fr)
TW (1) TW347333B (fr)
UA (1) UA41296C2 (fr)
WO (1) WO1993007163A1 (fr)
ZA (1) ZA927432B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307043D0 (en) * 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
GB2321455A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
RU2178710C1 (ru) * 2001-02-08 2002-01-27 Кожемякин Леонид Андреевич Индивидуальные вещества, полученные на основе химического взаимодействия дисульфидсодержащих пептидов с производными пуриновых или пиримидиновых оснований, фармацевтические композиции и препараты на их основе, способы их применения для лечения инфекционных заболеваний и профилактики осложнений
RU2328273C2 (ru) * 2001-12-19 2008-07-10 Рисерч Дивелопмент Фаундейшн Липосомальная доставка соединений, основанных на витамине е
GB0201179D0 (en) * 2002-01-18 2002-03-06 Angeletti P Ist Richerche Bio Therapeutic agents
TWI332507B (en) * 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
US9029345B2 (en) * 2005-03-16 2015-05-12 Case Western Reserve University Selective inhibitors of translesion DNA replication
WO2006101911A1 (fr) 2005-03-16 2006-09-28 Case Western Reserve University Inhibiteurs selectifs de la replication d'adn de translesion
NO324263B1 (no) * 2005-12-08 2007-09-17 Clavis Pharma Asa Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
PT1962808E (pt) * 2005-12-14 2010-10-29 Hoffmann La Roche Formulação de precursor de fármaco para o hcv
US8497292B2 (en) * 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
WO2008150438A1 (fr) * 2007-06-01 2008-12-11 Luitpold Pharmaceuticals, Inc. Conjugués pmea-lipides
US9296776B2 (en) 2007-07-09 2016-03-29 Eastern Virginia Medical School Substituted nucleoside derivatives with antiviral and antimicrobial properties
WO2009042767A1 (fr) * 2007-09-26 2009-04-02 Mount Sinai School Of Medicine Analogues d'azacytidine et leurs utilisations
US9988680B2 (en) 2011-09-01 2018-06-05 Case Western Reserve University Non-natural nucleosides as theranostic agents
US9493500B2 (en) 2012-07-19 2016-11-15 Richard Daifuku Fluorinated pyrimidine analogs and methods of use thereof
US9821173B2 (en) 2013-02-08 2017-11-21 Case Western Reserve University Anti-cancer agents and methods of use
RU2561501C1 (ru) * 2014-08-05 2015-08-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) Антиретровирусные препараты на основе производных азидотимидина
RU2621145C2 (ru) * 2015-11-03 2017-05-31 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежский государственный университет" (ФГБОУ ВПО "ВГУ") Способ получения липосом
EP3762396A1 (fr) * 2018-03-07 2021-01-13 GlaxoSmithKline Intellectual Property (No.2) Limited Composés utiles dans la thérapie du vih

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1325798A (en) 1970-09-24 1973-08-08 Upjohn Co Derivatives of 2,2-anhydro-ara-cytidine
US3920630A (en) * 1970-09-24 1975-11-18 Upjohn Co 2,2{40 -Anhydro-ara-cytidine compounds and process of preparation
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
DE3100478A1 (de) * 1981-01-09 1982-08-12 Dr. Thilo & Co GmbH, 8021 Sauerlach 5'ester von pyrimidinnucleosiden mit antiviraler wirksamkeit, verfahren zur herstellung und daraus hergestellte arzneimittel
US4355032B2 (en) 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
NZ201662A (en) 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
US4816447A (en) 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
US5250535A (en) 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4556659A (en) * 1982-08-09 1985-12-03 Syntex (U.S.A.) Inc. Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents
JPH0655755B2 (ja) 1985-01-23 1994-07-27 富山化学工業株式会社 新規な５−フルオロ−２′−デオキシウリジン−３′−ホスフエ−ト誘導体およびその塩
US4684631A (en) 1984-10-09 1987-08-04 Toyama Chemical Co., Ltd. Novel 5-fluoro-2-deoxyuridine derivatives and salts thereof, process for producing the same, and antitumor agents containing the same
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
DE3665260D1 (en) * 1985-05-07 1989-10-05 Teijin Ltd Antitumor agent
JPS6483092A (en) 1987-09-24 1989-03-28 Arakawa Chotaro & Co Novel n6,n6-dimethyladenosine derivative having carcinostatic activity, its production and carcinostatic agent containing said derivative as active component
EP0712629B1 (fr) * 1987-10-28 2003-06-18 Wellstat Therapeutics Corporation Dérivés acylés de déoxyribonucléoside et leurs utilisations
JPH0278696A (ja) 1988-09-13 1990-03-19 Shoichiro Ozaki ５−フルオロウラシル誘導体
IE980216A1 (en) * 1989-04-17 2000-02-23 Scotia Holdings Plc Anti-virals
FI105556B (fi) * 1991-09-30 2000-09-15 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta

Also Published As

Publication number Publication date
FI941574A0 (fi) 1994-04-06
UA41296C2 (uk) 2001-09-17
KR100272732B1 (ko) 2000-11-15
GB9121257D0 (en) 1991-11-20
RU2126417C1 (ru) 1999-02-20
MX9205715A (es) 1993-05-01
GB2260319A (en) 1993-04-14
NZ244535A (en) 1995-08-28
PL170846B1 (en) 1997-01-31
DE69219482T2 (de) 1997-10-23
DE69219482D1 (de) 1997-06-05
EP0642525B1 (fr) 1997-05-02
EP0642525A1 (fr) 1995-03-15
JPH06511249A (ja) 1994-12-15
AU672369B2 (en) 1996-10-03
US6548486B1 (en) 2003-04-15
NO941269D0 (no) 1994-04-07
HK1007430A1 (en) 1999-04-09
NO300014B1 (no) 1997-03-17
HUT68008A (en) 1995-05-29
FI990270A7 (fi) 1999-02-10
CZ288153B6 (en) 2001-05-16
CA2120725C (fr) 2000-04-11
DK0642525T3 (da) 1997-11-03
CA2120725A1 (fr) 1993-04-15
FI105035B (fi) 2000-05-31
GB2260319B (en) 1995-12-06
CZ80594A3 (en) 1994-12-15
AU2867392A (en) 1993-05-03
HU219400B (hu) 2001-04-28
HU9400988D0 (en) 1994-07-28
GR3024149T3 (en) 1997-10-31
FI941574L (fi) 1994-04-06
FI990270L (fi) 1999-02-10
SK281903B6 (sk) 2001-09-11
WO1993007163A1 (fr) 1993-04-15
SK39794A3 (en) 1994-10-05
IL103351A (en) 2000-02-17
FI990270A0 (fi) 1999-02-10
ATE152454T1 (de) 1997-05-15
TW347333B (en) 1998-12-11
JP2873313B2 (ja) 1999-03-24
SG47759A1 (en) 1998-04-17
IL103351A0 (en) 1993-03-15
NO941269L (no) 1994-04-07
CH0642525H1 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
SG47759A1 (en) Chemical compounds
TW340850B (en) Dextrin ester of fatty acids and use thereof
DK193488A (da) Saccharosefedtsyreester
CA2158853A1 (fr) Nouveaux composes antiviraux
TW341574B (en) METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION the invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings.
DE3884517D1 (de) Biologisch aktive carbonsaeureester.
AU3913989A (en) 9-Alkoxy phosphonate-guanine purine and adenine derivatives
CA2155329A1 (fr) Analogues d'acylfulvene, agents antitumeurs
EP0321777A3 (en) Process for the transesterification of fat and oil
IE810552L (en) Purines
CA2079889A1 (fr) Composes solides, non assimilables et renfermant des matieres grasses et compositions alimentaires contenant ces composes
ES2055407T3 (es) Analogos de acidos grasos oxi- o tio-sustituidos para ser utilizados en el tratamiento de infecciones retrovirales.
NO911322L (no) Nukleosid-derivater.
CA2092705A1 (fr) Compose presentant une action antitumorale, nsc-lsc1, et procede de fabrication dudit compose
AU4562089A (en) Sialic acid derivative with active ester groups
USD297140S (en) Simulated computer system
AU4425589A (en) Nucleoside derivatives
GB8714189D0 (en) Active tracker systems